MedTrace Logo

Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer

NCT02418624 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2019-01-16

No results posted yet for this study

Summary

A phase I trial to determine the recommended phase two dose of the combination of carboplatin and olaparib.

Conditions

Interventions

DRUG

carboplatin, olaparib

2 cycles of carboplatin and olaparib combination therapy followed by olaparib monotherapy.

Sponsors & Collaborators

  • The Netherlands Cancer Institute

    lead OTHER

Principal Investigators

  • Sabine Linn, MD, PhD · The Netherlands Cancer Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2019-01-31
Completion
2019-01-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02418624 on ClinicalTrials.gov